Typhoid Vaccines Market By Product and End User - Global Industry Analysis And Forecast To 2027
Published On : June 2022 Pages : 151 Category: Pharmaceuticals Report Code : HC063944
Typhoid Vaccines Market By Product (Vi Conjugate (Vi-REPA), Ty21a, Vi Conjugate (Vi-TT) and Vi Capsular Polysaccharide Vaccine) and End User (Clinics / Health Care Centers, Pharmacies and Hospitals) - Global Industry Analysis And Forecast To 2027
Industry Outlook
Typhoid is the bacterial disease that may lead to diarrhea, high fever, and vomiting. It very well may be deadly. It is brought about by the Salmonella typhi bacteria. The disease is regularly passed through the contaminated drinking water and food, and it is increasingly common in spots where handwashing is less successive. Therefore, the Typhoid Vaccines Market is anticipated to expand and has tremendous scope during the forecast period. The global Typhoid Vaccines Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Drivers & Restrains
The factors driving the market are; rise in the number of initiatives by the government, increasing in the number of cases related to typhoid, rising the number of immunization campaigns, increasing investment for the research & development of the vaccine by various companies of this market and few other factors.
Regional Insights
The North American region is leading the global Typhoid Vaccines Market owing to factor like; rising awareness in the people of this region, increasing demand for the vaccine for adults, infants & children’s, the vaccine available more easily and some other factors.
Typhoid Vaccines Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Johnson & Johnson
- AstraZeneca
- Sanofi
- GlaxoSmithKline plc
- Pfizer Inc.
- Merck & Co. Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Typhoid Vaccines Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Vi Conjugate (Vi-REPA)
o Ty21a
o Vi Conjugate (Vi-TT)
o Vi Capsular Polysaccharide Vaccine
o Typhoid Vaccines Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Clinics / Health Care Centers
o Pharmacies
o Hospitals
o Typhoid Vaccines Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Johnson & Johnson
o AstraZeneca
o Sanofi
o GlaxoSmithKline plc
o Pfizer Inc.
o Merck & Co. Inc.
o Typhoid Vaccines Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Typhoid Vaccines Market , By Country
o U.S. Typhoid Vaccines Market
o Canada Typhoid Vaccines Market
o Mexico Typhoid Vaccines Market
o Europe
§ Europe Typhoid Vaccines Market , By Country
o Germany Typhoid Vaccines Market
o UK Typhoid Vaccines Market
o France Typhoid Vaccines Market
o Russia Typhoid Vaccines Market
o Italy Typhoid Vaccines Market
o Rest of Europe Typhoid Vaccines Market
o Asia-Pacific
§ Asia-Pacific Typhoid Vaccines Market , By Country
o China Typhoid Vaccines Market
o Japan Typhoid Vaccines Market
o South Korea Typhoid Vaccines Market
o India Typhoid Vaccines Market
o Southeast Asia Typhoid Vaccines Market
o Rest of Asia-Pacific Typhoid Vaccines Market
o South America
§ South America Typhoid Vaccines Market , By Country
o Brazil Typhoid Vaccines Market
o Argentina Typhoid Vaccines Market
o Columbia Typhoid Vaccines Market
o Rest of South America Typhoid Vaccines Market
o Middle East and Africa
§ Middle East and Africa Typhoid Vaccines Market , By Country
o Saudi Arabia Typhoid Vaccines Market
o UAE Typhoid Vaccines Market
o Egypt Typhoid Vaccines Market
o Nigeria Typhoid Vaccines Market
o South Africa Typhoid Vaccines Market
o Rest of MEA Typhoid Vaccines Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Typhoid Vaccines Market, By Product
5.1. Introduction
5.2. Global Typhoid Vaccines Revenue and Market Share by Product (2017-2027)
5.2.1. Global Typhoid Vaccines Revenue and Revenue Share by Product (2017-2027)
5.3. Vi Conjugate (Vi-REPA)
5.3.1. Global Vi Conjugate (Vi-REPA) Revenue and Growth Rate (2017-2027)
5.4. Ty21a
5.4.1. Global Ty21a Revenue and Growth Rate (2017-2027)
5.5. Vi Conjugate (Vi-TT)
5.5.1. Global Vi Conjugate (Vi-TT) Revenue and Growth Rate (2017-2027)
5.6. Vi Capsular Polysaccharide Vaccine
5.6.1. Global Vi Capsular Polysaccharide Vaccine Revenue and Growth Rate (2017-2027)
6. Typhoid Vaccines Market, By End User
6.1. Introduction
6.2. Global Typhoid Vaccines Revenue and Market Share by End User (2017-2027)
6.2.1. Global Typhoid Vaccines Revenue and Revenue Share by End User (2017-2027)
6.3. Clinics / Health Care Centers
6.3.1. Global Clinics / Health Care Centers Revenue and Growth Rate (2017-2027)
6.4. Pharmacies
6.4.1. Global Pharmacies Revenue and Growth Rate (2017-2027)
6.5. Hospitals
6.5.1. Global Hospitals Revenue and Growth Rate (2017-2027)
7. Typhoid Vaccines Market, By Region
7.1. Introduction
7.2. Global Typhoid Vaccines Revenue and Market Share by Regions
7.2.1. Global Typhoid Vaccines Revenue by Regions (2017-2027)
7.3. North America Typhoid Vaccines by Countries
7.3.1. North America Typhoid Vaccines Revenue and Growth Rate (2017-2027)
7.3.2. North America Typhoid Vaccines Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Typhoid Vaccines by Countries
7.4.1. Europe Typhoid Vaccines Revenue and Growth Rate (2017-2027)
7.4.2. Europe Typhoid Vaccines Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Typhoid Vaccines by Countries
7.5.1. Asia-Pacific Typhoid Vaccines Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Typhoid Vaccines Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Typhoid Vaccines by Countries
7.6.1. South America Typhoid Vaccines Revenue and Growth Rate (2017-2027)
7.6.2. South America Typhoid Vaccines Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Typhoid Vaccines by Countries
7.7.1. Middle East and Africa Typhoid Vaccines Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Typhoid Vaccines Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Johnson & Johnson
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. AstraZeneca
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Sanofi
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. GlaxoSmithKline plc
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Pfizer Inc.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Merck & Co. Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
9. Typhoid Vaccines Market Forecast (2017-2027)
9.1. Global Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Typhoid Vaccines Market Forecast by Regions (2017-2027)
9.2.1. North America Typhoid Vaccines Market Forecast (2017-2027)
9.2.1.1. United States Typhoid Vaccines Market Forecast (2017-2027)
9.2.1.2. Canada Typhoid Vaccines Market Forecast (2017-2027)
9.2.1.3. Mexico Typhoid Vaccines Market Forecast (2017-2027)
9.2.2. Europe Typhoid Vaccines Market Forecast (2017-2027)
9.2.2.1. Germany Typhoid Vaccines Market Forecast (2017-2027)
9.2.2.2. France Typhoid Vaccines Market Forecast (2017-2027)
9.2.2.3. UK Typhoid Vaccines Market Forecast (2017-2027)
9.2.2.4. Russia Typhoid Vaccines Market Forecast (2017-2027)
9.2.2.5. Italy Typhoid Vaccines Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Typhoid Vaccines Market Forecast (2017-2027)
9.2.3. Asia-Pacific Typhoid Vaccines Market Forecast (2017-2027)
9.2.3.1. China Typhoid Vaccines Market Forecast (2017-2027)
9.2.3.2. Japan Typhoid Vaccines Market Forecast (2017-2027)
9.2.3.3. Korea Typhoid Vaccines Market Forecast (2017-2027)
9.2.3.4. India Typhoid Vaccines Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Typhoid Vaccines Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Typhoid Vaccines Market Forecast (2017-2027)
9.2.4. South America Typhoid Vaccines Market Forecast (2017-2027)
9.2.4.1. Brazil Typhoid Vaccines Market Forecast (2017-2027)
9.2.4.2. Argentina Typhoid Vaccines Market Forecast (2017-2027)
9.2.4.3. Columbia Typhoid Vaccines Market Forecast (2017-2027)
9.2.4.4. Rest of South America Typhoid Vaccines Market Forecast (2017-2027)
9.2.5. Middle East and Africa Typhoid Vaccines Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Typhoid Vaccines Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Typhoid Vaccines Market Forecast (2017-2027)
9.2.5.3. Egypt Typhoid Vaccines Market Forecast (2017-2027)
9.2.5.4. Nigeria Typhoid Vaccines Market Forecast (2017-2027)
9.2.5.5. South Africa Typhoid Vaccines Market Forecast (2017-2027)
9.2.5.6. Turkey Typhoid Vaccines Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Typhoid Vaccines Market Forecast (2017-2027)
9.3. Typhoid Vaccines Market Forecast by Product (2017-2027)
9.3.1. Typhoid Vaccines Forecast by Product (2017-2027)
9.3.2. Typhoid Vaccines Market Share Forecast by Product (2017-2027)
9.4. Typhoid Vaccines Market Forecast by End User (2017-2027)
9.4.1. Typhoid Vaccines Forecast by End User (2017-2027)
9.4.2. Typhoid Vaccines Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Typhoid Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Typhoid Vaccines Revenue and Revenue Share by Product (2017-2018)
Figure Global Vi Conjugate (Vi-REPA) Revenue and Growth Rate (2017-2018)
Figure Global Ty21a Revenue and Growth Rate (2017-2018)
Figure Global Vi Conjugate (Vi-TT) Revenue and Growth Rate (2017-2018)
Figure Global Vi Capsular Polysaccharide Vaccine Revenue and Growth Rate (2017-2018)
Table Global Typhoid Vaccines Revenue and Revenue Share by End User (2017-2018)
Figure Global Clinics / Health Care Centers Revenue and Growth Rate (2017-2018)
Figure Global Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Table Global Typhoid Vaccines Revenue by Regions (2017-2018)
Figure North America Typhoid Vaccines Growth Rate (2017-2018)
Figure North America Typhoid Vaccines Revenue and Growth Rate (2017-2018)
Figure North America Typhoid Vaccines by Countries (2017-2018)
Figure North America Typhoid Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure United States Typhoid Vaccines Growth Rate (2017-2018)
Figure United States Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Typhoid Vaccines Growth Rate (2017-2018)
Figure Canada Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Typhoid Vaccines Growth Rate (2017-2018)
Figure Mexico Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Typhoid Vaccines Growth Rate (2017-2018)
Figure Europe Typhoid Vaccines Revenue and Growth Rate (2017-2018)
Figure Europe Typhoid Vaccines by Countries (2017-2018)
Figure Europe Typhoid Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Germany Typhoid Vaccines Growth Rate (2017-2018)
Figure Germany Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Typhoid Vaccines Growth Rate (2017-2018)
Figure France Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Typhoid Vaccines Growth Rate (2017-2018)
Figure UK Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Typhoid Vaccines Growth Rate (2017-2018)
Figure Russia Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Typhoid Vaccines Growth Rate (2017-2018)
Figure Italy Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Typhoid Vaccines Growth Rate (2017-2018)
Figure Rest of Europe Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Typhoid Vaccines Growth Rate (2017-2018)
Figure Asia-Pacific Typhoid Vaccines Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Typhoid Vaccines by Countries (2017-2018)
Figure Asia-Pacific Typhoid Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure China Typhoid Vaccines Growth Rate (2017-2018)
Figure China Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Typhoid Vaccines Growth Rate (2017-2018)
Figure Japan Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Typhoid Vaccines Growth Rate (2017-2018)
Figure Korea Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Typhoid Vaccines Growth Rate (2017-2018)
Figure India Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Typhoid Vaccines Growth Rate (2017-2018)
Figure Southeast Asia Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Typhoid Vaccines Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Typhoid Vaccines Growth Rate (2017-2018)
Figure South America Typhoid Vaccines Revenue and Growth Rate (2017-2018)
Figure South America Typhoid Vaccines by Countries (2017-2018)
Figure South America Typhoid Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Typhoid Vaccines Growth Rate (2017-2018)
Figure Brazil Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Typhoid Vaccines Growth Rate (2017-2018)
Figure Argentina Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Typhoid Vaccines Growth Rate (2017-2018)
Figure Columbia Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Typhoid Vaccines Growth Rate (2017-2018)
Figure Rest of South America Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Typhoid Vaccines Growth Rate (2017-2018)
Figure Middle East and Africa Typhoid Vaccines Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Typhoid Vaccines by Countries (2017-2018)
Figure Middle East and Africa Typhoid Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Typhoid Vaccines Growth Rate (2017-2018)
Figure Saudi Arabia Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Typhoid Vaccines Growth Rate (2017-2018)
Figure United Arab Emirates Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Typhoid Vaccines Growth Rate (2017-2018)
Figure Egypt Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Typhoid Vaccines Growth Rate (2017-2018)
Figure Nigeria Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Typhoid Vaccines Growth Rate (2017-2018)
Figure South Africa Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Typhoid Vaccines Growth Rate (2017-2018)
Figure Turkey Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Typhoid Vaccines Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Table Johnson & Johnson Typhoid Vaccines Financial Overview
Table AstraZeneca Typhoid Vaccines Financial Overview
Table Sanofi Typhoid Vaccines Financial Overview
Table GlaxoSmithKline plc Typhoid Vaccines Financial Overview
Table Pfizer Inc. Typhoid Vaccines Financial Overview
Table Merck & Co. Inc. Typhoid Vaccines Financial Overview
Figure Global Typhoid Vaccines Revenue (Millions USD) and Growth Rate (2018-2025)
Table Typhoid Vaccines Market Forecast by Regions (2018-2025)
Figure North America Typhoid Vaccines Market Forecast (2018-2025)
Figure United States Typhoid Vaccines Market Forecast (2018-2025)
Figure Canada Typhoid Vaccines Market Forecast (2018-2025)
Figure Mexico Typhoid Vaccines Market Forecast (2018-2025)
Figure Europe Typhoid Vaccines Market Forecast (2018-2025)
Figure Germany Typhoid Vaccines Market Forecast (2018-2025)
Figure France Typhoid Vaccines Market Forecast (2018-2025)
Figure UK Typhoid Vaccines Market Forecast (2018-2025)
Figure Russia Typhoid Vaccines Market Forecast (2018-2025)
Figure Italy Typhoid Vaccines Market Forecast (2018-2025)
Figure Rest of Europe Typhoid Vaccines Market Forecast (2018-2025)
Figure Asia-Pacific Typhoid Vaccines Market Forecast (2018-2025)
Figure China Typhoid Vaccines Market Forecast (2018-2025)
Figure Japan Typhoid Vaccines Market Forecast (2018-2025)
Figure Korea Typhoid Vaccines Market Forecast (2018-2025)
Figure India Typhoid Vaccines Market Forecast (2018-2025)
Figure Southeast Asia Typhoid Vaccines Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Typhoid Vaccines Market Forecast (2018-2025)
Figure South America Typhoid Vaccines Market Forecast (2018-2025)
Figure Brazil Typhoid Vaccines Market Forecast (2018-2025)
Figure Argentina Typhoid Vaccines Market Forecast (2018-2025)
Figure Columbia Typhoid Vaccines Market Forecast (2018-2025)
Figure Rest of South America Typhoid Vaccines Market Forecast (2018-2025)
Figure Middle East and Africa Typhoid Vaccines Market Forecast (2018-2025)
Figure Saudi Arabia Typhoid Vaccines Market Forecast (2018-2025)
Figure United Arab Emirates Typhoid Vaccines Market Forecast (2018-2025)
Figure Egypt Typhoid Vaccines Market Forecast (2018-2025)
Figure Nigeria Typhoid Vaccines Market Forecast (2018-2025)
Figure South Africa Typhoid Vaccines Market Forecast (2018-2025)
Figure Turkey Typhoid Vaccines Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Typhoid Vaccines Market Forecast (2018-2025)
Figure Global Typhoid Vaccines Forecast by Product (2018-2025)
Figure Global Typhoid Vaccines Market Share Forecast by Product (2018-2025)
Figure Global Typhoid Vaccines Forecast by Product (2018-2025)
Figure Global Typhoid Vaccines Forecast by End User (2018-2025)
Figure Global Typhoid Vaccines Market Share Forecast by End User (2018-2025)
Figure Global Typhoid Vaccines Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|